TrueMark Investments LLC Reduces Stock Position in The Clorox Company $CLX

TrueMark Investments LLC cut its holdings in The Clorox Company (NYSE:CLX) by 91.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,430 shares of the company’s stock after selling 49,749 shares during the period. TrueMark Investments LLC’s holdings in Clorox were worth $447,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Clorox by 4.0% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock valued at $1,970,000 after purchasing an additional 514 shares in the last quarter. Woodline Partners LP grew its holdings in Clorox by 253.7% during the 1st quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock valued at $1,532,000 after buying an additional 7,465 shares in the last quarter. Global Retirement Partners LLC purchased a new position in Clorox during the 2nd quarter valued at about $224,000. Korea Investment CORP increased its position in shares of Clorox by 324.7% during the second quarter. Korea Investment CORP now owns 117,570 shares of the company’s stock valued at $14,117,000 after buying an additional 89,885 shares during the period. Finally, State Board of Administration of Florida Retirement System lifted its holdings in shares of Clorox by 0.6% in the second quarter. State Board of Administration of Florida Retirement System now owns 115,874 shares of the company’s stock worth $13,913,000 after buying an additional 710 shares in the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Stock Up 0.3%

CLX stock opened at $102.32 on Tuesday. The company’s 50 day moving average is $115.49 and its 200 day moving average is $111.99. The stock has a market cap of $12.37 billion, a price-to-earnings ratio of 16.72, a price-to-earnings-growth ratio of 0.50 and a beta of 0.59. The company has a current ratio of 0.74, a quick ratio of 0.48 and a debt-to-equity ratio of 71.03. The Clorox Company has a 1-year low of $96.66 and a 1-year high of $150.84.

Clorox (NYSE:CLX) last announced its earnings results on Tuesday, February 3rd. The company reported $1.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.43 by ($0.04). The company had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a net margin of 11.17% and a return on equity of 383.01%. The company’s revenue for the quarter was down .8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.55 earnings per share. Sell-side analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 8th. Investors of record on Wednesday, April 22nd will be given a $1.24 dividend. The ex-dividend date is Wednesday, April 22nd. This represents a $4.96 annualized dividend and a yield of 4.8%. Clorox’s payout ratio is 81.05%.

Analysts Set New Price Targets

A number of equities analysts have recently commented on CLX shares. Wall Street Zen upgraded shares of Clorox from a “sell” rating to a “hold” rating in a research report on Saturday, February 7th. Wells Fargo & Company set a $125.00 target price on shares of Clorox in a research note on Tuesday, February 17th. Rothschild & Co Redburn set a $117.00 price target on shares of Clorox in a report on Friday, February 13th. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Clorox from $112.00 to $101.00 and set a “hold” rating for the company in a research report on Monday. Finally, Morgan Stanley increased their price objective on Clorox from $125.00 to $136.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 5th. One analyst has rated the stock with a Buy rating, eleven have given a Hold rating and four have given a Sell rating to the company’s stock. According to data from MarketBeat, Clorox currently has a consensus rating of “Reduce” and a consensus target price of $118.00.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.